Machelle Sanders, Director: Biocryst Pharmaceuticals BCRX Sell · Filed 24/06/17

Trade details

Type: Insider sale
Amount: $28,134
Shares · price: 4,689 sh · $6.00 a share
Held after: 27,742 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Machelle SandersDirector
Trade date: 24/06/17
Filed: 24/06/17
Days to filing: 0 days

Sold 14.5% of holdings

Share of holding sold: 14.5%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/18~24/07/17

Machelle Sanders's recent trades

Machelle SandersDirector
Planned saleFortrea Holdings
Planned sale
Fortrea Holdings
FTRE
$174.7K
9,700 sh
$174.7K
Filed 08/03
Traded 08/03
Machelle SandersDirector
Sell10b5-1 planBiocryst Pharmaceuticals
Sell10b5-1 plan
Biocryst Pharmaceuticals
BCRX
$68.5K
9,600 sh
$68.5K
Filed 25/11/17
Traded 25/11/13
Machelle SandersDirector
Planned sale10b5-1 planBiocryst Pharmaceuticals
Planned sale10b5-1 plan
Biocryst Pharmaceuticals
BCRX
$68.5K
9,600 sh
$68.5K
Filed 25/11/13
Traded 25/11/13
Machelle SandersDirector
SellNovan
Sell
Novan
NOVN
$4,737
11,553 sh
$4,737
Filed 23/06/27
Traded 23/06/27
Machelle SandersDirector
SellBiocryst Pharmaceuticals
Sell
Biocryst Pharmaceuticals
BCRX
$31.9K
4,000 sh
$31.9K
Filed 23/06/15
Traded 23/06/15

Machelle Sanders, Director — sold $28.1K of Biocryst Pharmaceuticals BCRX · 14.5% of holdings | Whalegun